Samsara Bio Capital, LLC Decibel Therapeutics, Inc. Transaction History

Samsara Bio Capital, LLC

  • $194 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$2.08 - $4.79 $1.67 Million - $3.84 Million
801,629 New
801,629 $2.42 Million
Q2 2022

Aug 15, 2022
SELL
$1.85 - $4.21 $45,867 - $104,378
-24,793 Reduced 3.0%
801,629 $3.38 Million
Q1 2021

May 18, 2021
BUY
$10.56 - $19.9 $8.73 Million - $16.4 Million
826,422 New
826,422 $9.39 Million

About Decibel Therapeutics, Inc.

DBTX Quotes by TradingView
  • Ticker DBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,964,500
  • Description
  • Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to...
More about DBTX
Track This Portfolio

Track Samsara Bio Capital, LLC Portfolio

Follow Samsara Bio Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samsara Bio Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email